The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clinical Trial (CTMS) Market Research Report 2024
Synopsis
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global Clinical Trial (CTMS) market was valued at US$ 46670 million in 2023 and is anticipated to reach US$ 62370 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial (CTMS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial (CTMS).
Report Scope
The Clinical Trial (CTMS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trial (CTMS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial (CTMS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Oracle
Medidata Solutions
PAREXEL
IBM
ERT
Bioclinica
Forte Research Systems
Veeva Systems
MasterControl
MedNet Solutions
DSG
Bio-Optronics
DATATRAK
DZS Software Solutions
ArisGlobal
Segment by Type
Enterprise CTMS
Site CTMS
Segment by Application
Pharma & Biopharmaceutical Companies
Clinical Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial (CTMS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global Clinical Trial (CTMS) market was valued at US$ 46670 million in 2023 and is anticipated to reach US$ 62370 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial (CTMS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial (CTMS).
Report Scope
The Clinical Trial (CTMS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trial (CTMS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial (CTMS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Oracle
Medidata Solutions
PAREXEL
IBM
ERT
Bioclinica
Forte Research Systems
Veeva Systems
MasterControl
MedNet Solutions
DSG
Bio-Optronics
DATATRAK
DZS Software Solutions
ArisGlobal
Segment by Type
Enterprise CTMS
Site CTMS
Segment by Application
Pharma & Biopharmaceutical Companies
Clinical Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial (CTMS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial (CTMS) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enterprise CTMS
1.2.3 Site CTMS
1.3 Market by Application
1.3.1 Global Clinical Trial (CTMS) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharma & Biopharmaceutical Companies
1.3.3 Clinical Research Organizations
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial (CTMS) Market Perspective (2019-2030)
2.2 Clinical Trial (CTMS) Growth Trends by Region
2.2.1 Global Clinical Trial (CTMS) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Trial (CTMS) Historic Market Size by Region (2019-2024)
2.2.3 Clinical Trial (CTMS) Forecasted Market Size by Region (2025-2030)
2.3 Clinical Trial (CTMS) Market Dynamics
2.3.1 Clinical Trial (CTMS) Industry Trends
2.3.2 Clinical Trial (CTMS) Market Drivers
2.3.3 Clinical Trial (CTMS) Market Challenges
2.3.4 Clinical Trial (CTMS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial (CTMS) Players by Revenue
3.1.1 Global Top Clinical Trial (CTMS) Players by Revenue (2019-2024)
3.1.2 Global Clinical Trial (CTMS) Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Trial (CTMS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial (CTMS) Revenue
3.4 Global Clinical Trial (CTMS) Market Concentration Ratio
3.4.1 Global Clinical Trial (CTMS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial (CTMS) Revenue in 2023
3.5 Clinical Trial (CTMS) Key Players Head office and Area Served
3.6 Key Players Clinical Trial (CTMS) Product Solution and Service
3.7 Date of Enter into Clinical Trial (CTMS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial (CTMS) Breakdown Data by Type
4.1 Global Clinical Trial (CTMS) Historic Market Size by Type (2019-2024)
4.2 Global Clinical Trial (CTMS) Forecasted Market Size by Type (2025-2030)
5 Clinical Trial (CTMS) Breakdown Data by Application
5.1 Global Clinical Trial (CTMS) Historic Market Size by Application (2019-2024)
5.2 Global Clinical Trial (CTMS) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Trial (CTMS) Market Size (2019-2030)
6.2 North America Clinical Trial (CTMS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Trial (CTMS) Market Size by Country (2019-2024)
6.4 North America Clinical Trial (CTMS) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial (CTMS) Market Size (2019-2030)
7.2 Europe Clinical Trial (CTMS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Trial (CTMS) Market Size by Country (2019-2024)
7.4 Europe Clinical Trial (CTMS) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial (CTMS) Market Size (2019-2030)
8.2 Asia-Pacific Clinical Trial (CTMS) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Trial (CTMS) Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Trial (CTMS) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial (CTMS) Market Size (2019-2030)
9.2 Latin America Clinical Trial (CTMS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Trial (CTMS) Market Size by Country (2019-2024)
9.4 Latin America Clinical Trial (CTMS) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial (CTMS) Market Size (2019-2030)
10.2 Middle East & Africa Clinical Trial (CTMS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Trial (CTMS) Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Trial (CTMS) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Oracle
11.1.1 Oracle Company Detail
11.1.2 Oracle Business Overview
11.1.3 Oracle Clinical Trial (CTMS) Introduction
11.1.4 Oracle Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.1.5 Oracle Recent Development
11.2 Medidata Solutions
11.2.1 Medidata Solutions Company Detail
11.2.2 Medidata Solutions Business Overview
11.2.3 Medidata Solutions Clinical Trial (CTMS) Introduction
11.2.4 Medidata Solutions Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.2.5 Medidata Solutions Recent Development
11.3 PAREXEL
11.3.1 PAREXEL Company Detail
11.3.2 PAREXEL Business Overview
11.3.3 PAREXEL Clinical Trial (CTMS) Introduction
11.3.4 PAREXEL Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.3.5 PAREXEL Recent Development
11.4 IBM
11.4.1 IBM Company Detail
11.4.2 IBM Business Overview
11.4.3 IBM Clinical Trial (CTMS) Introduction
11.4.4 IBM Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.4.5 IBM Recent Development
11.5 ERT
11.5.1 ERT Company Detail
11.5.2 ERT Business Overview
11.5.3 ERT Clinical Trial (CTMS) Introduction
11.5.4 ERT Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.5.5 ERT Recent Development
11.6 Bioclinica
11.6.1 Bioclinica Company Detail
11.6.2 Bioclinica Business Overview
11.6.3 Bioclinica Clinical Trial (CTMS) Introduction
11.6.4 Bioclinica Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.6.5 Bioclinica Recent Development
11.7 Forte Research Systems
11.7.1 Forte Research Systems Company Detail
11.7.2 Forte Research Systems Business Overview
11.7.3 Forte Research Systems Clinical Trial (CTMS) Introduction
11.7.4 Forte Research Systems Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.7.5 Forte Research Systems Recent Development
11.8 Veeva Systems
11.8.1 Veeva Systems Company Detail
11.8.2 Veeva Systems Business Overview
11.8.3 Veeva Systems Clinical Trial (CTMS) Introduction
11.8.4 Veeva Systems Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.8.5 Veeva Systems Recent Development
11.9 MasterControl
11.9.1 MasterControl Company Detail
11.9.2 MasterControl Business Overview
11.9.3 MasterControl Clinical Trial (CTMS) Introduction
11.9.4 MasterControl Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.9.5 MasterControl Recent Development
11.10 MedNet Solutions
11.10.1 MedNet Solutions Company Detail
11.10.2 MedNet Solutions Business Overview
11.10.3 MedNet Solutions Clinical Trial (CTMS) Introduction
11.10.4 MedNet Solutions Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.10.5 MedNet Solutions Recent Development
11.11 DSG
11.11.1 DSG Company Detail
11.11.2 DSG Business Overview
11.11.3 DSG Clinical Trial (CTMS) Introduction
11.11.4 DSG Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.11.5 DSG Recent Development
11.12 Bio-Optronics
11.12.1 Bio-Optronics Company Detail
11.12.2 Bio-Optronics Business Overview
11.12.3 Bio-Optronics Clinical Trial (CTMS) Introduction
11.12.4 Bio-Optronics Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.12.5 Bio-Optronics Recent Development
11.13 DATATRAK
11.13.1 DATATRAK Company Detail
11.13.2 DATATRAK Business Overview
11.13.3 DATATRAK Clinical Trial (CTMS) Introduction
11.13.4 DATATRAK Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.13.5 DATATRAK Recent Development
11.14 DZS Software Solutions
11.14.1 DZS Software Solutions Company Detail
11.14.2 DZS Software Solutions Business Overview
11.14.3 DZS Software Solutions Clinical Trial (CTMS) Introduction
11.14.4 DZS Software Solutions Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.14.5 DZS Software Solutions Recent Development
11.15 ArisGlobal
11.15.1 ArisGlobal Company Detail
11.15.2 ArisGlobal Business Overview
11.15.3 ArisGlobal Clinical Trial (CTMS) Introduction
11.15.4 ArisGlobal Revenue in Clinical Trial (CTMS) Business (2019-2024)
11.15.5 ArisGlobal Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
